Surya P. Pandey, Donghui Yang, Lee Hedden, Colin R. Laughlin, Weihong Wang, Ariadna S. Soto, Halah Winner, Luzmariel Medina Sanchez, Edith E. Campana, Clarisse Engl, Yanlin Zeng, Mohit Rana, Lauren Van Der Kraak, Mackenzie J. Bender, Joshua Prokopec, Julia M. Ferrick, Xinan Meng, Erica Fong, Mai Sun, Steven J. Mullett, Reinhard Hinterleitner
{"title":"Gasdermin C cleavage by Cathepsin S modulates Rab7 vesicles in intestinal epithelial cells to amplify anti-helminth immunity","authors":"Surya P. Pandey, Donghui Yang, Lee Hedden, Colin R. Laughlin, Weihong Wang, Ariadna S. Soto, Halah Winner, Luzmariel Medina Sanchez, Edith E. Campana, Clarisse Engl, Yanlin Zeng, Mohit Rana, Lauren Van Der Kraak, Mackenzie J. Bender, Joshua Prokopec, Julia M. Ferrick, Xinan Meng, Erica Fong, Mai Sun, Steven J. Mullett, Reinhard Hinterleitner","doi":"10.1016/j.immuni.2025.06.018","DOIUrl":null,"url":null,"abstract":"Gasdermins are canonically associated with plasma membrane pore formation and lytic cell death. Gasdermin C (GsdmC), predominantly expressed in intestinal epithelial cells (IECs), seems to operate independently of these canonical roles. Here, we show that activated GsdmC is increased in response to type 2 immunity in the gut, driven by Cathepsin S (CTSS)-mediated cleavage. Although IEC cell death is not the main consequence of GsdmC cleavage, inserting a single amino acid (aa) within the lipid-binding motif to match that of the other gasdermins enhanced GsdmC oligomerization and increased GsdmC-mediated cell death. Mechanistically, instead of localizing to the plasma membrane, we showed that cleaved GsdmC targeted Rab7<sup>+</sup> vesicles, such as late endosomes. This modulated lipid droplet accumulation, which promoted goblet cell hyperplasia and type 2 immune responses. These findings demonstrate how GsdmC in IEC protects against helminth infection and expands the role of gasdermins beyond cell death and cytokine release.","PeriodicalId":13269,"journal":{"name":"Immunity","volume":"83 1","pages":""},"PeriodicalIF":25.5000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunity","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.immuni.2025.06.018","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Gasdermins are canonically associated with plasma membrane pore formation and lytic cell death. Gasdermin C (GsdmC), predominantly expressed in intestinal epithelial cells (IECs), seems to operate independently of these canonical roles. Here, we show that activated GsdmC is increased in response to type 2 immunity in the gut, driven by Cathepsin S (CTSS)-mediated cleavage. Although IEC cell death is not the main consequence of GsdmC cleavage, inserting a single amino acid (aa) within the lipid-binding motif to match that of the other gasdermins enhanced GsdmC oligomerization and increased GsdmC-mediated cell death. Mechanistically, instead of localizing to the plasma membrane, we showed that cleaved GsdmC targeted Rab7+ vesicles, such as late endosomes. This modulated lipid droplet accumulation, which promoted goblet cell hyperplasia and type 2 immune responses. These findings demonstrate how GsdmC in IEC protects against helminth infection and expands the role of gasdermins beyond cell death and cytokine release.
气真皮层通常与质膜孔形成和溶解性细胞死亡有关。Gasdermin C (GsdmC)主要在肠上皮细胞(IECs)中表达,似乎独立于这些规范的作用。在这里,我们发现激活的GsdmC在响应肠道2型免疫时增加,由组织蛋白酶S (CTSS)介导的裂解驱动。虽然IEC细胞死亡不是GsdmC切割的主要后果,但在脂质结合基序中插入单个氨基酸(aa)以匹配其他gasdermins的氨基酸,可增强GsdmC寡聚化并增加GsdmC介导的细胞死亡。在机制上,我们发现裂解的GsdmC不是定位于质膜,而是靶向Rab7+囊泡,如晚期核内体。这调节了脂滴积累,促进杯状细胞增生和2型免疫反应。这些发现证明了GsdmC在IEC中如何保护寄生虫免受感染,并将气皮素的作用扩展到细胞死亡和细胞因子释放之外。
期刊介绍:
Immunity is a publication that focuses on publishing significant advancements in research related to immunology. We encourage the submission of studies that offer groundbreaking immunological discoveries, whether at the molecular, cellular, or whole organism level. Topics of interest encompass a wide range, such as cancer, infectious diseases, neuroimmunology, autoimmune diseases, allergies, mucosal immunity, metabolic diseases, and homeostasis.